David D. Chang - 02 Feb 2026 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Reporting relationship: President and CEO, Director
Issuer ticker: ALLO
Reported as of: 02 Feb 2026
Net transaction value: -$171,484
SEC form: 4
Accepted by SEC: 04 Feb 2026, 17:18:18 UTC
Prior SEC filing: 18 Mar 2025
Next SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/Earl Douglas, Attorney-in-Fact

Key filing fact

David D. Chang filed Form 4 for Allogene Therapeutics, Inc. (ALLO) on 04 Feb 2026.

Key facts

This page summarizes David D. Chang's Form 4 filing for Allogene Therapeutics, Inc. (ALLO).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 04 Feb 2026, 17:18.

Change

Previous filing in this sequence was filed on 18 Mar 2025.
Current net transaction value: -$171,484.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001611024 Primary reporting owner

Chang David D

Relationship: President and CEO, Director
Address: 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Signature: /s/Earl Douglas, Attorney-in-Fact
Signature date: 04 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALLO transaction

Common Stock

Sale

Transaction value: $171,484
Shares: -95,269
Change %: -1.8%
Price: $1.80
Shares after: 5,185,862
Date: 02 Feb 2026
Ownership: Direct
Footnotes: F1, F2, F3

ALLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 856,044
Date: 02 Feb 2026
Ownership: See footnote
Footnotes: F4

ALLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 856,044
Date: 02 Feb 2026
Ownership: See footnote
Footnotes: F5

ALLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,201,108
Date: 02 Feb 2026
Ownership: See footnote
Footnotes: F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALLO transaction Derivative

Stock Option (Right to buy)

Award

Transaction value: $0
Shares: +1,387,931
Change %
Price: $0.000000
Shares after: 1,387,931
Date: 02 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,387,931
Exercise price: $1.87
Footnotes: F7

ALLO transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +392,586
Change %
Price: $0.000000
Shares after: 392,586
Date: 02 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 392,586
Exercise price
Footnotes: F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.71 to $1.87, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F3

Includes 4,562 shares of the Issuer's common stock acquired by the reporting person on September 15, 2025 pursuant to an employee stock purchase program.

Footnote F4

Securities held in the name of the RTC 2019 Trust dated October 1, 2019.

Footnote F5

Securities held in the name of the JEC 2019 Trust dated October 1, 2019.

Footnote F6

Securities held in the name of the Chang 2006 Family Trust

Footnote F7

25% of the shares subject to the stock option shall vest on February 2, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Footnote F8

Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal annual installments over the four-year period measured from February 2, 2026, subject to continued service through the vesting date.